Nuffield Department of Primary Care Health Sciences set to deliver clinical trials expertise to China National Biotec Group in new collaboration
28 November 2023
The training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.
16 June 2023
Through a strategic partnership with UNSW and the University of Oxford, Prof Michael Kidd, will start in a new joint position in the Nuffield Department of Primary Care Health Sciences (NDPCHS), focusing upon Global Primary Care and Future Health Systems.
Clinician-patient communication about emergency aerial medical evacuation in case of infectious disease
1 February 2023
New research from the University of Oxford, published today in the Journal of Travel Medicine, has developed a simple six-step check list clinicians can use to improve communication, decision making and planning about the possibility and practicalities of Aerial Medical Evacuation (AME).
17 April 2020
Researchers from Oxford University are now enrolling participants into the first clinical trial of potential COVID-19 treatments to take place in GP practices.
14 April 2020
Researchers from University of Oxford's Nuffield Department of Primary Care Health Sciences have played a key role in developing rapid guidance on managing suspected or confirmed pneumonia in adults in the community.
13 December 2019
On average, countries implemented just under half of the 18 non-communicable disease (NCD) policies recommended by WHO in 2017, and implementation is slowly improving over time.
9 October 2017
The ORNATE INDIA project has been awarded £6 million from RCUK's Global Challenges Research Fund, and includes researchers from Oxford University, Moorfields Eye Hospital and Imperial College London.
12 October 2016
Dr Merlin Willcox wins RCGP Global Health Dragon’s Den
11 February 2016
GPs across England, Northern Ireland and Wales are less likely to follow recommendations for definitive action for cancer referral and diagnosis than their non-UK counterparts.
4 February 2016
How quickly should a drug be withdrawn from the market if it causes harm? It sounds like a simple question, but the answer depends on where you live, Oxford University researchers have found.